+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Andexanet Alfa, Idarucizumab, Phytonadione (Vitamin K)), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 6032449
Description Jump to:
The global anticoagulant reversal drugs market size is expected to reach USD 2.78 billion by 2030. It is expected to expand at a CAGR of 12.3% from 2025 to 2030. The rising number of bleeding disorders, the introduction of new drugs, and the growing number of cases requiring anticoagulant therapies are some of the factors anticipated to foster market growth during the forecast period.

In October 2015, Praxbind (idarucizumab) by Boehringer Ingelheim Pharmaceuticals was approved as an anticoagulant reversal drug indicated for patients treated with Pradaxa (dabigatran) during emergency surgery or uncontrolled or life-threatening bleeding. Hence, the availability of these anticoagulation reversal drugs allows doctors and patients to consider such treatment options with greater confidence, therefore boosting the demand for anticoagulant reversal drugs.

Bleeding disorders like hemophilia can be acquired or inherited. However, other bleeding disorders can occur from conditions, such as HIV, anemia, leukemia, cirrhosis of the liver, and vitamin K deficiency. According to the National Heart, Lung, and Blood Institute, more than 3 million people in the U.S. are affected with anemia, which is the most common blood disorder. The Leukemia & Lymphoma Society (LLS) stated that in the year 2020, the number of people expected to be diagnosed with leukemia is around 60,530. A rise in bleeding disorders is increasing the demand for anticoagulants, thus fueling the market growth.

However, the high cost of these reversal therapies is anticipated to restrain the market growth. As per the American College of Cardiology, 4-F PCC (Kcentra) helps in treating bleeding cases caused by rivaroxaban and apixaban and it is dosed at 50 units/kg. Its average wholesale price is USD 2.90 per unit, therefore treating a patient whose weight is 100 kg would cost around USD 14,500.

Anticoagulant Reversal Drugs Market Report Highlights

  • The idarucizumab segment dominated the market, with a revenue share of 36.8% in 2024, driven by its high specificity for dabigatran as an effective option for reversing anticoagulation in emergencies.
  • Hospital pharmacies dominated the market with the largest revenue share of 48.6% in 2024, driven by the need for immediate access to anticoagulant reversal agents in emergencies.
  • North America anticoagulant reversal drugs market dominated the global market with a revenue share of 38.6% in 2024.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Anticoagulant Reversal Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Anticoagulant Reversal Drugs Market: Product Type Business Analysis
4.1. Product Type Market Share, 2024 & 2030
4.2. Product Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product Type, 2018 to 2030 (USD Million)
4.4. Prothrombin Complex Concentrates
4.4.1. Prothrombin Complex Concentrates Market, 2018 - 2030 (USD Million)
4.5. Phytonadione (Vitamin K)
4.5.1. Phytonadione (Vitamin K) Market, 2018 - 2030 (USD Million)
4.6. Andexanet Alfa
4.6.1. Andexanet Alfa Market, 2018 - 2030 (USD Million)
4.7. Idarucizumab
4.7.1. Idarucizumab Market, 2018 - 2030 (USD Million)
4.8. Protamine
4.8.1. Protamine Market, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Anticoagulant Reversal Drugs Market: Distribution Channel Business Analysis
5.1. Distribution Channel Market Share, 2024 & 2030
5.2. Distribution Channel Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
5.4. Hospital Pharmacy
5.4.1. Hospital Pharmacy Market, 2018 - 2030 (USD Million)
5.5. Retail Pharmacy
5.5.1. Retail Pharmacy Market, 2018 - 2030 (USD Million)
5.6. Online Pharmacy
5.6.1. Online Pharmacy Market, 2018 - 2030 (USD Million)
Chapter 6. Anticoagulant Reversal Drugs Market: Regional Estimates & Trend Analysis by Product Type
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.4. North America
6.4.1. North America Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Framework
6.4.2.3. Competitive Insights
6.4.2.4. U.S. Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Framework
6.4.3.3. Competitive Insights
6.4.3.4. Canada Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Framework
6.4.4.3. Competitive Insights
6.4.4.4. Mexico Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Europe
6.5.1. Europe Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework
6.5.2.3. Competitive Insights
6.5.2.4. UK Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Framework
6.5.3.3. Competitive Insights
6.5.3.4. Germany Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Framework
6.5.4.3. Competitive Insights
6.5.4.4. France Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Regulatory Framework
6.5.5.3. Competitive Insights
6.5.5.4. Italy Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Regulatory Framework
6.5.6.3. Competitive Insights
6.5.6.4. Spain Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. Norway
6.5.7.1. Key Country Dynamics
6.5.7.2. Regulatory Framework
6.5.7.3. Competitive Insights
6.5.7.4. Norway Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.8. Denmark
6.5.8.1. Key Country Dynamics
6.5.8.2. Regulatory Framework
6.5.8.3. Competitive Insights
6.5.8.4. Denmark Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.9. Sweden
6.5.9.1. Key Country Dynamics
6.5.9.2. Regulatory Framework
6.5.9.3. Competitive Insights
6.5.9.4. Sweden Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework
6.6.2.3. Competitive Insights
6.6.2.4. Japan Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework
6.6.3.3. Competitive Insights
6.6.3.4. China Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework
6.6.4.3. Competitive Insights
6.6.4.4. India Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. South Korea
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework
6.6.5.3. Competitive Insights
6.6.5.4. South Korea Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Australia
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework
6.6.6.3. Competitive Insights
6.6.6.4. Australia Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework
6.6.7.3. Competitive Insights
6.6.7.4. Thailand Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Latin America
6.7.1. Latin America Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework
6.7.2.3. Competitive Insights
6.7.2.4. Brazil Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework
6.7.3.3. Competitive Insights
6.7.3.4. Argentina Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. MEA
6.8.1. MEA Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework
6.8.2.3. Competitive Insights
6.8.2.4. South Africa Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework
6.8.3.3. Competitive Insights
6.8.3.4. Saudi Arabia Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Regulatory Framework
6.8.4.3. Competitive Insights
6.8.4.4. UAE Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Regulatory Framework
6.8.5.3. Competitive Insights
6.8.5.4. Kuwait Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Anticoagulant Reversal Drugs Market: Regional Estimates & Trend Analysis by Distribution Channel
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.4. North America
7.4.1. North America Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework
7.4.2.3. Competitive Insights
7.4.2.4. U.S. Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework
7.4.3.3. Competitive Insights
7.4.3.4. Canada Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory Framework
7.4.4.3. Competitive Insights
7.4.4.4. Mexico Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Europe
7.5.1. Europe Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework
7.5.2.3. Competitive Insights
7.5.2.4. UK Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework
7.5.3.3. Competitive Insights
7.5.3.4. Germany Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework
7.5.4.3. Competitive Insights
7.5.4.4. France Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework
7.5.5.3. Competitive Insights
7.5.5.4. Italy Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory Framework
7.5.6.3. Competitive Insights
7.5.6.4. Spain Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Norway
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory Framework
7.5.7.3. Competitive Insights
7.5.7.4. Norway Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Denmark
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory Framework
7.5.8.3. Competitive Insights
7.5.8.4. Denmark Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Sweden
7.5.9.1. Key Country Dynamics
7.5.9.2. Regulatory Framework
7.5.9.3. Competitive Insights
7.5.9.4. Sweden Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework
7.6.2.3. Competitive Insights
7.6.2.4. Japan Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework
7.6.3.3. Competitive Insights
7.6.3.4. China Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework
7.6.4.3. Competitive Insights
7.6.4.4. India Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework
7.6.5.3. Competitive Insights
7.6.5.4. South Korea Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework
7.6.6.3. Competitive Insights
7.6.6.4. Australia Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Regulatory Framework
7.6.7.3. Competitive Insights
7.6.7.4. Thailand Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework
7.7.2.3. Competitive Insights
7.7.2.4. Brazil Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Framework
7.7.3.3. Competitive Insights
7.7.3.4. Argentina Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. MEA
7.8.1. MEA Anticoagulant Reversal Drugs Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework
7.8.2.3. Competitive Insights
7.8.2.4. South Africa Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework
7.8.3.3. Competitive Insights
7.8.3.4. Saudi Arabia Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Framework
7.8.4.3. Competitive Insights
7.8.4.4. UAE Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Regulatory Framework
7.8.5.3. Competitive Insights
7.8.5.4. Kuwait Anticoagulant Reversal Drugs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Pfizer Inc
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. AstraZeneca
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Dr. Reddy’s Laboratories Ltd
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Endo International plc
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Teva Pharmaceutical Industries Ltd
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Sun Pharmaceutical Industries Ltd
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Mylan N.V.
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Novartis AG.
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Lupin
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Cipla Inc
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global anticoagulant reversal drugs market, by region, 2018 - 2030 (USD Million)
Table 4. Global anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 5. Global anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 6. North America anticoagulant reversal drugs market, by country, 2018 - 2030 (USD Million)
Table 7. North America anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 8. North America anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 9. U.S. anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 10. U.S. anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 11. Canada anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 12. Canada anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 13. Mexico anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 14. Mexico anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 15. Europe anticoagulant reversal drugs market, by country, 2018 - 2030 (USD Million)
Table 16. Europe anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 17. Europe anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 18. UK anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 19. UK anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 20. Germany anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 21. Germany anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 22. France anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 23. France anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 24. Italy anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 25. Italy anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 26. Spain anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 27. Spain anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 28. Norway anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 29. Norway anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 30. Denmark anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 31. Denmark anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 32. Sweden anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 33. Sweden anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 34. Asia Pacific anticoagulant reversal drugs market, by country, 2018 - 2030 (USD Million)
Table 35. Asia Pacific anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 36. Asia Pacific anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 37. Japan anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 38. Japan anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 39. China anticoagulant reversal drugs market, by product type, 2018-2030 (USD Million)
Table 40. China anticoagulant reversal drugs market, by distribution channel, 2018-2030 (USD Million)
Table 41. India anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 42. India anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 43. Australia anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 44. Australia anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 45. South Korea anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 46. South Korea anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 47. Thailand anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 48. Thailand anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 49. Latin America anticoagulant reversal drugs market, by country, 2018 - 2030 (USD Million)
Table 50. Latin America anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 51. Latin America anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Billion
Table 52. Brazil anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 53. Brazil anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 54. Argentina anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 55. Argentina anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 56. Middle East & Africa anticoagulant reversal drugs market, by country, 2018 - 2030 (USD Million)
Table 57. Middle East & Africa anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 58. Middle East & Africa anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 59. South Africa anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 60. South Africa anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 62. Saudi Arabia anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 63. UAE anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 64. UAE anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
Table 65. Kuwait anticoagulant reversal drugs market, by product type, 2018 - 2030 (USD Million)
Table 66. Kuwait anticoagulant reversal drugs market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Anticoagulant reversal drugs market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Product type outlook (USD Billion)
Fig. 10 Distribution channel outlook (USD Billion)
Fig. 11 Competitive landscape
Fig. 12 Anticoagulant reversal drugs market dynamics
Fig. 13 Anticoagulant reversal drugs market: Porter’s five forces analysis
Fig. 14 Anticoagulant reversal drugs market: PESTLE analysis
Fig. 15 Anticoagulant reversal drugs market: Product type segment dashboard
Fig. 16 Anticoagulant reversal drugs market: Product type market share analysis, 2024 & 2030
Fig. 17 Prothrombin complex concentrates market, 2018 - 2030 (USD Million)
Fig. 18 Phytonadione (Vitamin K) market, 2018 - 2030 (USD Million)
Fig. 19 Andexanet alfa market, 2018 - 2030 (USD Million)
Fig. 20 Idarucizumab market, 2018 - 2030 (USD Million)
Fig. 21 Protamine market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Anticoagulant reversal drugs market: Distribution channel segment dashboard
Fig. 24 Anticoagulant reversal drugs market: Distribution channel market share analysis, 2024 & 2030
Fig. 25 Hospital pharmacy market, 2018 - 2030 (USD Million)
Fig. 26 Retail pharmacy market, 2018 - 2030 (USD Million)
Fig. 27 Online pharmacy market, 2018 - 2030 (USD Million)
Fig. 28 Anticoagulant reversal drugs market revenue, by region
Fig. 29 Regional marketplace: Key takeaways
Fig. 30 North America anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 31 U.S. country dynamics
Fig. 32 U.S. anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 33 Canada country dynamics
Fig. 34 Canada anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 35 Mexico country dynamics
Fig. 36 Mexico anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 37 Europe anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 38 UK country dynamics
Fig. 39 UK anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 40 Germany country dynamics
Fig. 41 Germany anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 42 France country dynamics
Fig. 43 France anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 44 Italy country dynamics
Fig. 45 Italy anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 46 Spain country dynamics
Fig. 47 Spain anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 48 Norway country dynamics
Fig. 49 Norway anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 50 Sweden country dynamics
Fig. 51 Sweden anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 52 Denmark country dynamics
Fig. 53 Denmark anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 55 Japan country dynamics
Fig. 56 Japan anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 57 China country dynamics
Fig. 58 China anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 59 India country dynamics
Fig. 60 India anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 61 Australia country dynamics
Fig. 62 Australia anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 63 South Korea country dynamics
Fig. 64 South Korea anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 65 Thailand country dynamics
Fig. 66 Thailand anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 67 Latin America anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 68 Brazil country dynamics
Fig. 69 Brazil anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 70 Argentina country dynamics
Fig. 71 Argentina anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 72 MEA anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 73 South Africa country dynamics
Fig. 74 South Africa anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 75 Saudi Arabia country dynamics
Fig. 76 Saudi Arabia anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 77 UAE country dynamics
Fig. 78 UAE anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 79 Kuwait country dynamics
Fig. 80 Kuwait anticoagulant reversal drugs market, 2018 - 2030 (USD Million)
Fig. 81 Company categorization
Fig. 82 Company market position analysis
Fig. 83 Strategic framework

Companies Mentioned

  • Pfizer Inc
  • AstraZeneca
  • Dr. Reddy’s Laboratories Ltd
  • Endo International plc
  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd
  • Mylan N.V.
  • Novartis AG
  • Lupin
  • Cipla Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.38 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.78 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Anticoagulant Reversal Drugs Market by Product, Distribution - Global Forecast 2025-2030 - Product Image

Anticoagulant Reversal Drugs Market by Product, Distribution - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Anticoagulant Reversal Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Image

Anticoagulant Reversal Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • 120 Pages
  • Global
From
Anticoagulant Reversal Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Image

Anticoagulant Reversal Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • 115 Pages
  • Global
From
Anticoagulant Reversal Drugs Market 2022-2026 - Product Image

Anticoagulant Reversal Drugs Market 2022-2026

  • Report
  • 120 Pages
  • Global
From
Anticoagulants - Global Strategic Business Report - Product Image

Anticoagulants - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.